Pharmaceutical Manufacturing Software Market Report 2026

The pharmaceutical manufacturing software market size has grown rapidly in recent years. It will grow from $3.82 billion in 2025 to $4.43 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to increasing pharmaceutical production demands, rising regulatory requirements, adoption of erp systems in pharma, growth of biopharmaceutical companies, need for quality management solutions.

The pharmaceutical manufacturing software market size is expected to see rapid growth in the next few years. It will grow to $7.87 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to integration of AI and ml in manufacturing processes, cloud-based software adoption, expansion of smart manufacturing facilities, enhanced process analytical technology adoption, growth of contract research organizations. Major trends in the forecast period include real-time production monitoring, regulatory compliance automation, supply chain optimization tools, quality control and capa management, laboratory workflow automation.

The rising level of drug production is expected to support the growth of the pharmaceutical manufacturing software market in the coming years. Drug production includes the systematic development, testing, formulation, and packaging of pharmaceutical products to ensure safety, quality, and effectiveness. Increased drug production is essential to meet growing healthcare needs, address global public health challenges, and ensure timely availability of treatments. Pharmaceutical manufacturing software enhances production processes by improving data accuracy, optimizing resource allocation, streamlining workflows, and supporting regulatory compliance. For example, in April 2025, according to ScienceDirect, a Netherlands-based scientific publication platform, 1,035 new drugs were approved between January 2023 and October 2024, including 426 classified as novel drugs. As a result, rising drug production levels are reinforcing demand for pharmaceutical manufacturing software.

Leading companies operating in the pharmaceutical manufacturing software market are focusing on process optimization through the integration of smart manufacturing technologies, such as AI-powered tools, to strengthen predictive analytics, optimize manufacturing operations, and improve overall operational efficiency. An AI-powered tool in pharmaceutical manufacturing software uses artificial intelligence to optimize processes, enhance quality control, and support improved decision-making throughout drug production. For example, in February 2024, Mareana, a US-based provider of AI-powered analytics and supply chain solutions for the pharmaceutical and life sciences industries, launched Connect CMC, an AI-powered tool designed to transform data management for small pharmaceutical and biotech companies. It improves efficiency, accuracy, and cost-effectiveness by automating data extraction from paper batch records and ensuring GxP compliance, supporting digital transformation in drug development.

In May 2023, Antares Vision Group, an Italy-based provider of industrial solutions, acquired Smart Point Technologies for an undisclosed amount. This acquisition is intended to strengthen Antares Vision Group’s end-to-end solution portfolio by integrating Smart Point Technologies’ specialized software expertise, improving operational efficiency, supporting compliance with stringent regulatory requirements, and expanding its overall market presence. Smart Point Technologies is an India-based provider of pharmaceutical manufacturing software solutions.

Major companies operating in the pharmaceutical manufacturing software market are McKesson Corporation, Oracle Corporation, SAP SE, ABB Ltd., Rockwell Automation Inc., Dassault Systèmes SE, NetSuite Inc., The Sage Group plc, Epicor Software Corporation, QAD Inc., Intellect Design Arena Ltd., Columbus Manufacturing Inc., MasterControl Inc., Sapphire Systems Ltd., DESKERA PTE LTD, Vormittag Associates Inc., Logic ERP Solutions Pvt Ltd., SYSPRO (Pty) Ltd., Datacor Inc., BatchMaster Software Inc., Fishbowl Inc., Aquilon Software Inc., CompuTec S.A., ERPAG Inc., MRPeasy Ltd.

North America was the largest region in the pharmaceutical manufacturing software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical manufacturing software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the pharmaceutical manufacturing software market by increasing the costs of importing software solutions, cloud infrastructure, and specialized tools used for production and compliance. Regions like Asia-Pacific and Europe, which rely heavily on imported software for MES, ERP, LIMS, and QMS systems, are most impacted, slowing adoption among large enterprises and small-to-mid-sized pharmaceutical companies. On-premises and cloud-based deployment segments face higher operational costs due to tariffs. On the positive side, tariffs are encouraging local development of pharmaceutical manufacturing software and investment in domestic cloud infrastructure, promoting innovation and reducing long-term dependence on imports.

The pharmaceutical manufacturing software market research report is one of a series of new reports that provides pharmaceutical manufacturing software market statistics, including pharmaceutical manufacturing software industry global market size, regional shares, competitors with a pharmaceutical manufacturing software market share, detailed pharmaceutical manufacturing software market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical manufacturing software industry. This pharmaceutical manufacturing software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmaceutical manufacturing software consists of specialized applications designed to manage, control, and optimize various processes involved in producing pharmaceutical products. These solutions integrate with manufacturing systems to streamline operations, ensure regulatory compliance, and boost overall efficiency.

The main types of pharmaceutical manufacturing software include manufacturing execution systems (MES), enterprise resource planning (ERP) systems, laboratory information management systems (LIMS), quality management systems (QMS), process analytical technology (PAT) systems, and regulatory compliance software. MES solutions oversee and control production processes on the factory floor, managing workflows, monitoring real-time operations, and ensuring that production processes are executed accurately and efficiently. They track materials, personnel, and equipment throughout the manufacturing process to improve productivity and product quality. These systems can be deployed on-premises, via the cloud, or through a hybrid approach, and cater to large enterprises, small businesses, and midsize companies. End-users include biopharmaceutical companies, medical device manufacturers, contract research organizations, academic research institutions, and others.

The pharmaceutical manufacturing software market consists of revenues earned by entities providing services such as software implementation services, customization, maintenance, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical manufacturing software market also includes sales of predictive analytics tools, electronic batch record (EBR) systems, data integration, and management tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.